<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03956914</url>
  </required_header>
  <id_info>
    <org_study_id>CTCF2_2016_DSW</org_study_id>
    <nct_id>NCT03956914</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Deep Sea Water on the Blood Glucose Level</brief_title>
  <official_title>A 8-weeks, Randomized, Double-blind, Placebo-Controlled, Cross-Over Clinical Trials to Evaluated the Efficacy and Safety of Deep Sea Water on Blood Glucose Level</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chonbuk National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kyungpook National University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Chonbuk National University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study was conducted to investigate the effects of daily supplementation of deep sea
      water on improvement of hyperglycemia
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study was a 8 weeks, randomized, double-blind, placebo-controlled, cross-over clinical
      trial.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2, 2016</start_date>
  <completion_date type="Actual">August 28, 2017</completion_date>
  <primary_completion_date type="Actual">April 24, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes of blood glucose</measure>
    <time_frame>Baseline, 8 weeks</time_frame>
    <description>Concentration of fasting and postprandial glucose during OGTT (oral glucose tolerance test) were assessed before and after the intervention</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes of blood insulin</measure>
    <time_frame>Baseline, 8 weeks</time_frame>
    <description>Concentration of blood insulin were assessed before and after the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>C-pepetide</measure>
    <time_frame>Baseline, 8 weeks</time_frame>
    <description>Concentration of C-peptide were assessed before and after the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HbA1c</measure>
    <time_frame>Baseline, 8 weeks</time_frame>
    <description>Concentration of HbA1c were assessed before and after the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Homeostatic model assessment - insulin resistance (HOMA-IR)</measure>
    <time_frame>Baseline, 8 weeks</time_frame>
    <description>Concentration of HOMA-IR were assessed before and after the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total cholesterol</measure>
    <time_frame>Baseline, 8 weeks</time_frame>
    <description>Concentration of total cholesterol were assessed before and after the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Triglyceride</measure>
    <time_frame>Baseline, 8 weeks</time_frame>
    <description>Concentration of triglyceride were assessed before and after the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HDL-cholesterol</measure>
    <time_frame>Baseline, 8 weeks</time_frame>
    <description>Concentration of HDL-cholesterol were assessed befor and after the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LDL-cholesterol</measure>
    <time_frame>Baseline, 8 weeks</time_frame>
    <description>Concentration of LDL-cholesterol were assessed befor and after the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight</measure>
    <time_frame>Baseline, 8 weeks</time_frame>
    <description>Concentration of weight were assessed befor and after the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BMI</measure>
    <time_frame>Baseline, 8 weeks</time_frame>
    <description>Concentration of BMI were assessed before and after the invervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body fat mass</measure>
    <time_frame>Baseline, 8 weeks</time_frame>
    <description>Concentration of body fat mass were assessed before and after the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent of body fat mass</measure>
    <time_frame>Baseline, 8 weeks</time_frame>
    <description>Concentration of percent of body fass mass were assessed before and after the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist circumference</measure>
    <time_frame>Baseline, 8 weeks</time_frame>
    <description>Concentration of waist circumference were assessed before and after the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist-hip ratio (WHR)</measure>
    <time_frame>Baseline, 8 weeks</time_frame>
    <description>Concentration of WHR were assessed before and after the intervention</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>PreDiabetes</condition>
  <arm_group>
    <arm_group_label>DSW (deep sea water) group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>DSW, 440 ml/day for 8 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo, 440 ml/day for 8 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placeob water 440 ml/day for 8 weeks</description>
    <arm_group_label>Placebo group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Deep sea water</intervention_name>
    <description>Deep sea water 440 ml/day for 8 weeks</description>
    <arm_group_label>DSW (deep sea water) group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Fasting plasma glucose concentration of 100-140 mg/dL or 2h-postprandial plasma
             glucose concentration of 140 ~199 mg/dL

        Exclusion Criteria:

          -  Patients with type 1 or type 2 diabetes

          -  HbA1c â‰¥9.0%

          -  Weight decreased by more than 10% within past 3 months

          -  Have clinically significant acute or chronic cardiovascular system, endocrine system,
             immune system, respiratory system, hepatic biliary system, kidney and Urinary system,
             neuropsychiatry, musculoskeletal, inflammatory and hematologic malignancies,
             gastrointestinal disorders, etc.

          -  Hypoglycemic agent, obesity medicine, lipid lowering agent within past 6 months or
             functional food within past 2 month

          -  Subjects who have taken corticosteroid within past 1 months

          -  History of alcohol or substance abuse

          -  Participation in any other clinical trials within past 2 months

          -  Laboratory test by show the following results

               -  Serum AST (aspartate aminotransferase) or ALT (alanine aminotransferase) &gt; 2
                  times the upper limit of normal range

               -  Serum Creatinine &gt; 2.0 mg/dl

          -  Pregnancy or breast feeding

          -  If a woman of childbearing doesn't accept the implementation of appropriate
             contraception

          -  Principal Investigator judged inappropriate for participation in study because of
             Laboratory test result, etc
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>May 17, 2019</study_first_submitted>
  <study_first_submitted_qc>May 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2019</study_first_posted>
  <last_update_submitted>January 13, 2020</last_update_submitted>
  <last_update_submitted_qc>January 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chonbuk National University Hospital</investigator_affiliation>
    <investigator_full_name>Soo-Wan Chae</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prediabetic State</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

